Urinary Bag Market Segment Overview, Regional Analysis and Forecast to 2031

The global urinary bag market will rise at a CAGR of 4.4% CAGR between 2021 and 2031.

Between 2016 and 2020, the global urinary bag market grew at a moderate CAGR of more than 3.5%. According to a World Health Organization (WHO) report, the prevalence of urine incontinence in population-based studies ranged from 9.9% to 36.1% (2-4), with older women being twice as likely as older men. Urinary bags are frequently employed in the treatment of urine incontinence, ulcerative colitis, retention, and spinal cord injury.

According to the Continence Foundation of Australia, around 38% of women and 13% of men in Australia were affected by urinary incontinence in 2019, accounting for more than one in every three Australians. According to the survey, the illness is more common in women (61%), persons with arthritis (57%), diabetes (46%), impairments (47%), mental health disorders (53%), and males with prostate problems (54%).

The United States controls more than 90% of the North American market. The United States' healthcare system is well-known for its infrastructure and spending. Applications in cancer care facilities and hospitals are determined by rules and insurance policies, which promotes the country's market growth.

According to the Urology Care Foundation, 40 percent of women and 30 percent of men in the United States experienced overactive bladder symptoms in 2019.

Germany is estimated to expand at a CAGR of 5% through 2031, reaching a valuation of US$ 270 Million.

Germany is a world leader in pharmaceutical and healthcare product manufacturing. Manufacturers in the country have built a competitive environment by manufacturing products and utilising cutting-edge research to increase functioning.

Browse More@ https://www.futuremarketinsights.com/reports/urinary-bag-market

Some of the leading companies operating in the market are:

  • Medline Industries, Inc.
  • Cardinal Health, Inc.
  • Hollister Incorporated
  • Teleflex Incorporated
  • Cook Medical
  • Moore Medical LLc
  • Mckesson Medical-Surgical Inc.
  • Arcus Medical LLc
  • Urocare
  • Covidien
  • Others

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Antidiabetics Market to reach US$ 223 billion by 2032, growing at a 9.6% CAGR from 2022 to 2032 | Future Market Insights, Inc.

Image
The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market's expansion. The ageing baby boomer population is another factor driving the market during the forecast period. According to the International Diabetes Federation, the global diabetes incidence will increase from 366 million in 2011 to 552 million by 2030. During the forecast period, the industry is expected to benefit from a significant increase in the number of diabetic patients. Furthermore, new product development is expected to benefit the market in the near future. For example, Novo Nordisk, a Danish pharmaceutical company, announced the launch of oral semaglutide for the treatment of Type 2 diabetes in India in January 2022. Furthermore, the development of advanced pumps based on smart technologies like AI and ML is expected to open up a slew of new doors. For exampl
Read more